Federal Supply Schedule 36F79719D0167

Award Date 5/15/19
Last Date to Order 4/30/25
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Millicent U.S., Inc. The contract has a period of performance from May 1, 2025 to April 30, 2030 and a ceiling value of $24,867,460.00. The purpose of this FSS contract is to provide the VA with drugs, pharmaceuticals, and hematology-related products under the 65 I B product category. As an FSS contract, it allows the VA and other federal agencies to place orders for these supplies and...
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, is for the procurement of drugs, pharmaceuticals, and hematology-related products. The prime contractor is Validus Pharmaceuticals, LLC, a for-profit limited liability company that manufactures goods. The contract has a ceiling value of $2,420,310.00 and a period of performance from April 1, 2023 to March 31, 2028. As a Federal Supply Schedule contract, it is a...
The Federal Supply Schedule contract with ID 36F79724D0124 was awarded to Mericon Industries Inc., a small business, by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to provide pharmaceutical and hematology-related products. The contract has a ceiling value of $225,000.00 and a period of performance from June 1, 2024 to May 31, 2029. This multiple award Federal Supply Schedule contract falls under the 65 I B product category, "DRUGS, PHARMACEUTICALS, &...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Metacel Pharmaceuticals LLC, a for-profit organization. The contract is for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B of the Federal Supply Schedule. The contract has a ceiling value of $25,000.00 and a period of performance from August 4, 2024, to January 31, 2025. This is an interim agreement with no...
This federal contract IDV is a Federal Supply Schedule (FSS) award under Schedule 65 I B for Drugs, Pharmaceuticals, and Hematology Related Products. The contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs, to Meitheal Pharmaceuticals, Inc., a for-profit foreign-owned manufacturer. The contract has a ceiling value of $25,000.00 and a period of performance from the award date of December 2, 2024 through May...
The Federal Supply Schedule contract award with ID 36F79723D0228 was granted to Mission Pharmacal Company, a for-profit manufacturer, by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency. The contract has a ceiling value of $3,000,000.00 and a performance period of September 15, 2023 through September 14, 2028. The contract is for the procurement of Drugs, Pharmaceuticals, & Hematology Related Products under Schedule 65 I B. The scope of the contract includes...
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) to Vifor Pharma Inc., provides for the procurement of drugs, pharmaceuticals, and hematology-related products. The contract has a total ceiling value of $85,200,000 and a period of performance extending to February 28, 2028. As a Federal Supply Schedule contract, this vehicle allows for the efficient procurement of the specified medical and pharmaceutical products by federal agencies, including...
The Federal Supply Schedule contract is awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract, valued up to $1,155,030.00, has an ultimate completion date of August 31, 2029 and was awarded to Soleva Pharma LLC, a for-profit limited liability company, on September 1, 2024. The contract is for the procurement of 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS for VISN 12. As a Federal Supply Schedule...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 IB, which covers Drugs, Pharmaceuticals, and Hematology Related Products. The contract was awarded to HLS Therapeutics Inc., a for-profit manufacturer, on July 1, 2022 by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract has a ceiling value of $13,848,500.00 and a period of performance through June 30, 2027. It is a multiple award...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to ITF Therapeutics LLC, a foreign-owned, self-certified small disadvantaged business. The contract is for INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, with a ceiling value of $25,000.00 and a period of performance through May 14, 2025. As a Federal Supply Schedule contract, this is a multiple award vehicle...

This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Millicent U.S., Inc. The contract has a ceiling value of $250,000.00 and a period of performance through April 30, 2025.

The contract is for pharmaceutical and hematology-related products under GSA Schedule 65 IB - Drugs, Pharmaceuticals, & Hematology Related Products. As a Federal Supply Schedule contract, it is a multiple award vehicle that allows federal agencies to purchase the contracted products and services. The solicitation and contract do not indicate any set-asides were used. Millicent U.S., Inc. is the prime contractor on this IDV award.

Generated 5/4/25, 12:58 AM